We sold a BioPen System to Rockefeller University
We have sold a BioPen® Prime System to Rockefeller University, NYC, USA. The BioPen® System enables researchers to specifically expose individual cells, parts of cells and tissues to very small amounts of drugs. Rockefeller University is a well-known university and the oldest biomedical research institute in the USA.
CEO Victoire Viannay comments:
“We’re pleased to have established a customer relationship with Rockefeller University in USA. We assess that this will strengthen our brand and provide, once again, the company with a well-known reference customer for future sales.”
Rockefeller University has ordered a complete BioPen® Prime System, which was installed in April 1st, 2019. The BioPen® System is a platform solution that enables researchers to specifically expose individual cells, parts of cells and tissues to very small amounts of drugs. The series consists of BioPen® PRIME and BioPen® FLEX, which are designed to fit the two most common types of microscope in laboratory research. Both products are tailor-made to enable cost-effective drug development and medical research and are primarily focused on academics, research laboratories and pharmaceutical and biotech companies.